Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

25551
1
BuzzFeed, Inc. BuzzFeed Reports $189.9M Revenue in 2024, Faces 18% Decline and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

25552
1
BrightSpring Health Services, Inc. BrightSpring Health Services Reports 27.6% Revenue Growth to $11.3 Billion in 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25553
1
Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals Reports $334.3 Million Net Loss for 2024 Amid Commercial Launch of VOQUEZNA

Via official filing (AI summary) | over 1 year ago | 0 comments

25554
1
Bridgewater Bancshares Inc Bridgewater Bancshares Reports 17.9% Decrease in Net Income for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25555
1
ALERUS FINANCIAL CORP Alerus Financial Corporation Reports 52% Increase in Net Income for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25556
1
GUARANTY BANCSHARES INC /TX/ Guaranty Bancshares Reports $3.12 Billion in Total Assets and $31.5 Million Net Earnings for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25557
1
Oxford Square Capital Corp. Oxford Square Capital Corp. Reports $26.4 Million Net Investment Income for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25558
1
Teucrium Commodity Trust Teucrium Commodity Trust Reports $47.86 Million Net Loss for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25559
1
Vroom, Inc. Vroom, Inc. Reports $165.1 Million Net Loss for 2024, Emerges from Chapter 11 Bankruptcy

Via official filing (AI summary) | over 1 year ago | 0 comments

25560
1
Summit Midstream Corp Summit Midstream Corporation Reports $113.175 Million Net Loss for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25561
1
Owlet, Inc. Owlet Reports $12.5 Million Net Loss in 2024, Revenue Increases 44.5%

Via official filing (AI summary) | over 1 year ago | 0 comments

25562
1
Third Coast Bancshares, Inc. Third Coast Bancshares Reports 42.7% Increase in Net Income to $47.67 Million for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25563
1
TriplePoint Venture Growth BDC Corp. TriplePoint Venture Growth BDC Reports $32M Net Increase in Assets for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25564
1
GRAIL, Inc. GRAIL Reports $2.027 Billion Net Loss and 35% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25565
1
Editas Medicine, Inc. Editas Medicine Reports $237.1 Million Net Loss for 2024, Revenue Declines to $32.3 Million

Via official filing (AI summary) | over 1 year ago | 0 comments

25566
1
Lyell Immunopharma, Inc. Lyell Immunopharma Reports $342.99 Million Net Loss and Acquires ImmPACT Bio USA Inc.

Via official filing (AI summary) | over 1 year ago | 0 comments

25567
1
Verrica Pharmaceuticals Inc. Verrica Pharmaceuticals Reports $76.6 Million Net Loss for 2024, Increased Product Revenue

Via official filing (AI summary) | over 1 year ago | 0 comments

25568
1
Mural Oncology plc Mural Oncology Reports $128.5 Million Net Loss for 2024, Decreased R&D Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments

25569
1
Tvardi Therapeutics, Inc. Cara Therapeutics Reports $70.9 Million Net Loss for 2024, Revenue Declines to $7.1 Million

Via official filing (AI summary) | over 1 year ago | 0 comments

25570
1
WEBTOON Entertainment Inc. WEBTOON Entertainment Reports $152.9 Million Net Loss Despite 5.1% Revenue Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

25571
1
Dianthus Therapeutics, Inc. /DE/ Dianthus Therapeutics Reports $84.97 Million Net Loss and $6.24 Million Revenue for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25572
1
Zymeworks Inc. Zymeworks Reports $122.7 Million Net Loss for 2024, Revenue Increases to $76.3 Million

Via official filing (AI summary) | over 1 year ago | 0 comments

25573
1
Voyager Therapeutics, Inc. Voyager Therapeutics Reports $65M Net Loss and $80M Revenue for 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

25574
1
Astria Therapeutics, Inc. Astria Therapeutics Reports $94.26 Million Net Loss for 2024, Driven by Increased R&D Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments

25575
1
FATE THERAPEUTICS INC Fate Therapeutics Reports $186.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments